🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06605612
Enrolling by invitation Observational

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

NCT06605612 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-09-09
Last updated
2025-09-10

Condition(s) studied

Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular DystrophiesPompe DiseaseMyasthenia GravisLambert-Eaton-SyndromeAmyotrophic Lateral SclerosisSpinal Muscular AtrophyGuillain-Barré SyndromeChronic Inflammatory Demyelinating PolyneuropathyFriedreich AtaxiaHereditary Motor Sensory Neuropathy

Investigational drug(s) / intervention(s)

FBIndex

FBIndex: There will be no intervention.

Study summary

Currently, there are no standardised fall risk scores or guidelines on when to use appropriate assistive gait devices (AGDs) for people with neuromuscular disorders (NMDs). There is a clear medical unmet need to provide a battery of appropriate locomotor gait assessments to determine the risk of falling for patients with NMDs and give clear guidelines to prescribe an appropriate AGD.

The primary goal is to confirm whether the clinical battery assessments (Heel-Rise Test (HRT), Chair-Rise Test (CRT), Semi-tandem Stand (STS), Trunk-Rise Test (TRT), Foot-Tapping Test (FTT), Timed Up and Go (TUG), 10-Meter-Walk Test (10MWT) and 6-Minute-Walk Test (6MWT) can be validated and generalized to other NMD target populations that meet broader eligibility criteria based on used clinical assessments. The second objective of this project is to provide intra- and inter-observer reliability and test-retest reliability of included clinical assessments used to determine the risk of falling for patients with NMDs. Finally, all data will be compared with norm data from the healthy population (n=15) collected retrospectively.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Only patients with adequate cognitive and communicative function to give informed consent and to fill out the scale assessing the risk of falling will be included. Exclusion Criteria: * Patients who are unable to walk without AGD for at least 10 meters. * Patients who had knee, hip or back surgery in the last three months. * Patients who suffer from polyneuropathy or peripheral neuropathy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München München Bavaria

More LMU Klinikum trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06605612 on ClinicalTrials.gov ↗ ← All trials in Germany